Abstract: A process produces an organic compound by allowing (A) a compound capable of generating a free radical to react with (B) at least one of esters and salts of nitrous acid in the presence of a nitrogen-containing cyclic compound constitutively having a skeleton represented by following Formula (i) in its ring:
wherein X is an oxygen atom or an —OR group, and wherein R is a hydrogen atom or a hydroxyl-protecting group. Examples of the nitrogen-containing cyclic compound are cyclic imide compounds having a cyclic imide skeleton represented by following Formula (I):
wherein n is 0 or 1; X is an oxygen atom or an —OR group, and wherein R is a hydrogen atom or a hydroxyl-protecting group.
Abstract: Oximes are prepared by reacting carbonyl compounds, hydrogen peroxide and ammonia in the presence of a catalyst system comprising a catalyst comprising titanium, silicon and oxygen and a cocatalyst comprising an acidic solid comprising an organic or inorganic support material, where either the support material itself has Lewis-acid or Brönsted acid properties, or Lewis-acid or Brönsted-acid functional groups are applied to the support material.
Type:
Grant
Filed:
September 26, 2001
Date of Patent:
May 20, 2003
Assignee:
Degussa AG
Inventors:
Georg Friedrich Thiele, Steffen Hasenzahl, Thomas Schiffer
Abstract: Carbon monolith-supported catalysts with high leach resistance used in catalytic applications involving strong acidic and basic conditions in a pH range of from 0 to 6.5 and from 7.5 to 14, are respectively described. The leach resistance of the catalyst system originates from strong interaction between the catalyst and the unsaturated valence of the carbon surface. In addition to surprisingly high resistance to leach out, the catalysts also have substantial differential advantages in catalyst performance: catalyst activity, selectivity, and stability.
Abstract: Benzoyl derivatives of the formula (I), process for their preparation and their use as herbicides and plant growth regulators are described.
In this formula (I), R1, R2, R3, R4 and R5 are various organic radicals, Q is isothiazole, isoxazole, cyclohexanedione or a &bgr;-ketonitrile radical and A, B, E and X are divalent units containing one or more atoms.
Type:
Grant
Filed:
September 2, 1999
Date of Patent:
October 2, 2001
Assignee:
Hoechst Schering AgrEvo GmbH
Inventors:
Andreas Van Almsick, Lothar Willms, Thomas Auler, Hermann Bieringer, Christopher Rosinger
Abstract: The invention relates to processes for preparing substituted aromatic amino compounds which contain at least one unsaturated --CN bond or carbonyl group on the aromatic radical or in a side chain, by catalytic hydrogenation of appropriate substituted aromatic nitro compounds in the presence of a modified noble metal catalyst of platinum which is modified with a metal selected from lead, mercury, bismuth, germanium, cadmium, arsenic, antimony, silver and gold.
Abstract: Pyrazol-4-ylbenzoyl compounds of the formula I ##STR1## where Z is a 5- or 6-membered heterocyclic saturated or unsaturated radical, Q is a pyrazole ring and L and M are as defined in the specification, their use as herbicidal compounds and to processes for preparing the compounds.
Type:
Grant
Filed:
July 30, 1997
Date of Patent:
December 8, 1998
Assignee:
BASF Aktiengesellschaft
Inventors:
Wolfgang von Deyn, Regina Luise Hill, Uwe Kardorff, Stefan Engel, Martina Otten, Marcus Vossen, Peter Plath, Harald Rang, Albrecht Harreus, Hartmann Konig, Helmut Walter, Karl-Otto Westphalen, Ulf Misslizt
Abstract: Partially hydrogenated derivatives of 2-nitro-1,1,1-trifluoroalkanes, in particular 2-oximino- and 2-hydroxylamino-1,1,1-trifluoroalkanes, are prepared by catalytically hydrogenating 2-nitro-1,1,1-trifluoroalkanes until a maximum of 2.2 moles of hydrogen per mole of 2-nitro-1,1,1-trifluoroalkane have reacted.
Type:
Grant
Filed:
September 21, 1984
Date of Patent:
November 11, 1986
Assignee:
Bayer Aktiengesellschaft
Inventors:
Bernd Baasner, Heinz Ziemann, Erich Klauke
Abstract: A method for the production of dichloroformoxime is disclosed in which chloropicrin is dissolved in a nonbasic aprotic organic solvent together with anhydrous hydrogen chloride, and said chloropicrin is reduced to dichloroformoxime in said solution in the presence of powdered tin acting as both a reactant and catalyst. The reaction is preferably carried out in tetrahydrofuran using at least 15 grams of dissolved hydrogen chloride per 100 grams of solvent and chloropicrin in an amount of at least 50% of the weight of the hydrogen chloride. The powdered tin is used in an amount of at least about 1 mole of tin per mole of chloropicrin, and the reaction temperature is preferably about 0.degree. C.